Perfil
Oliver Buck is the founder of OncoBeta GmbH.
He is currently a Trustee at the International Centers for Precision Oncology Foundation and a Member-Supervisory Board at ITM Isotope Technologies Munich SE.
Previously, he served as a Non-Independent Non-Executive Director at Telix Pharmaceuticals Ltd. from 2017 to 2022.
Mr. Buck graduated from Technische Universität München.
Cargos activos de Oliver Buck
| Empresas | Cargo | Inicio |
|---|---|---|
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology Manufactures and supplies medical radioisotopes for diagnosis and targeted treatment of various cancer indications | Director/Miembro de la Junta | 01/01/2012 |
International Centers for Precision Oncology Foundation | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Oliver Buck.
| Empresas | Cargo | Fin |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Director/Miembro de la Junta | 18/05/2022 |
OncoBeta GmbH
OncoBeta GmbH Medical SpecialtiesHealth Technology Operates as a medical device and radiochemical company | Fundador | - |
Formación de Oliver Buck.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
OncoBeta GmbH
OncoBeta GmbH Medical SpecialtiesHealth Technology Operates as a medical device and radiochemical company | Health Technology |
International Centers for Precision Oncology Foundation | |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology Manufactures and supplies medical radioisotopes for diagnosis and targeted treatment of various cancer indications | Health Technology |
- Bolsa de valores
- Insiders
- Oliver Buck
















